Over-the-Counter Antibiotics: What the Law Actually Says and Where Patients Go When We Say No

Over-the-Counter Antibiotics: What the Law Actually Says and Where Patients Go When We Say No

A peer-to-peer look at the grey market your “no” is competing with, and the prescribing landscape we weren’t trained for

By Dr. Jamie Wilkey, PharmD — Director of Clinical Strategy, Jase
Edited and approved by Kristen Carpenter, PA-C — Clinical Advisory Board Member

Most prescribers can give a clean “no” to the contingency antibiotics question in their sleep. The patient asks about keeping a course on hand. You walk through the resistance picture and the documented harms of self-treating viral illness with leftover prescriptions. The clinical answer is sound. 

However, your firm “no” doesn’t end the patient’s access to antibiotics from other sources. It moves the conversation somewhere you can’t see. Your patient opens their phone and types “buy antibiotics over the counter” into Google. Or “fish amoxicillin.” Or “antibiotics without prescription USA.” Now they’re really entering a murky, unsafe place in their search. 

I’ve stood at the pharmacy counter and had patients ask almost every day what aisle the OTC antibiotics are on. And those traveling from outside the US are always always shocked that we have nothing (aside from creams and ointments) available OTC for them to purchase without a prescription.

Are Antibiotics Available Over the Counter in the US?

No.

Every systemic antibiotic in the US is federally prescription-only under Section 503(b) of the Food, Drug, and Cosmetic Act¹. Every oral. Every injectable. Every IV. There is no OTC pathway, and there hasn’t been one in decades.

The only meaningful exceptions are topical: bacitracin, neomycin, and polymyxin (the triple-antibiotic ointment trio), available without a script for surface use. None of them treat the conditions patients are searching for when they type “buy antibiotics online.” We all know nobody is stockpiling Neosporin for a UTI at sea.

So the legal answer is clear: no antibiotics over the counter. The harder question is whether the clean legal answer is actually the answer your patient is satisfied by.

We Weren’t Trained For The System We’re Practicing In

This is the part most CE courses haven’t caught up to.

Pharmacy school, medical school, and PA school all taught us to prescribe inside a closed system. One patient. One prescriber. One chart. One local pharmacy that had a relationship to all of the above and a pharmacist who would call when something looked off.

That system isn’t the system anymore. Your patient today has access to:

• Direct-to-consumer telehealth platforms (Hims, Hers, Sesame Care, Push Health, GoodRx, Cost Plus, and a long list of others) that prescribe after a laughably thin intake with no synchronous visit and no real clinical review behind the script
• Mail-order chains and Amazon Pharmacy shipping from warehouses outside your local network and outside your visibility
• Foreign mail-order pharmacies advertising “no prescription needed” and shipping product from manufacturing chains the FDA has never inspected
• Cross-border purchasing in Mexico and elsewhere, where many antibiotics are functionally OTC
• Pet stores stocking aquarium amoxicillin, doxycycline, and cephalexin on the same shelf as goldfish food
• Friends, family, and online communities passing along leftover prescriptions, often paired with TikTok dosing advice from creators whose credentials don’t exist

None of these channels talk to each other. None of them talk to you. Your patient is the only person holding the full picture, and most patients are not pharmacists.

Antibiotics are over-prescribed and we all know it. Sometimes the script is clinically indicated. Sometimes it’s the fastest way to end a visit with a patient convinced they have a sinus infection. Patients have noticed. When the same clinic that gave a friend a Z-Pak for a cold turns around and tells them no for a real concern, the “no” lands as arbitrary.

We were trained to be the gatekeepers of a system that no longer has gates. Patients have noticed before we have. The job now is harder than the one we trained for: guiding patients to appropriate access, especially for antibiotics, in a landscape where access is everywhere and quality is uneven.

Where Patients Actually Go When We Say No

Fish antibiotics are the version of the story we’ve all heard. The newer version is worse. Here’s the shape of the grey market today:

• Online “telehealth” prescribers running rubber-stamp intakes and writing whatever the patient asked for, with no real clinical relationship behind the script. Some are licensed in one state and prescribing into fifty. Some are pharmacy-owned and incentivized to write.
• Foreign mail-order pharmacies shipping product the FDA has flagged as counterfeit or mislabeled at non-trivial rates. The FDA runs BeSafeRx² as a standing consumer warning because the volume of unlicensed online pharmacies grew large enough to require one.
• Cross-border purchases, primarily in Mexico, where many antibiotics are sold without a prescription. The product is often legitimate. The clinical guidance attached to it is essentially nonexistent.
• Aquarium and livestock antibiotics, which are not manufactured to USP standards, not tested for human dissolution profiles, and may contain dyes or fillers cleared only for fish.
• Leftover-prescription swapping between friends, family, and online communities, often guided by content from creators whose credentials don’t exist.

(You’re saying, ok, but my patients can spot the obvious scams. Some can. The packaging and designs on the dangerous channels are convincing enough that some can’t.)

What unites all of these is what they lack: a real clinical relationship, written guidance, a recall pathway, recourse if the batch is bad. Speed is what the patient sees first. The cost shows up later, if at all.

What Appropriate Medical Preparation Actually Looks Like

There is a legal, clinically sound version of what these patients are looking for. We call it appropriate medical preparation, and it has four pieces:

• A US-licensed clinician running a real clinical evaluation behind every script
• Pharmaceutical-grade medications, manufactured to USP standards
• A US-licensed pharmacy as the dispensing point of record
• Written clinical guidance, in the patient’s hands, for when and how to use what was prescribed

Same medications your patients were already searching for. Held to the standards of care you practice.

In no way a replacement for primary care. Complex diagnoses, chronic conditions, and ongoing provider relationships belong in the exam room with you. Appropriate medical preparation works in a narrow space: well-defined, common, low-acuity conditions where the evidence is strong and the patient’s actual problem is access, not diagnosis.

Who’s Doing This Work

Jase.com is a family team of medical doctors, physician assistants, and pharmacists who have been working in appropriate preparation space for over five years. The clinical team includes board-certified family medicine providers, an extreme-medicine and disaster medicine specialist, and a Director of Pharmacy licensed across twenty states. The clinical work happens on the front end, so the patient isn’t doing it alone at 11pm.

Charting the Grey Area in Public

This is the contingency category we’re building, and we’re building it carefully. There are plenty of online resources in this space that aren’t reputable or safe, and most weren’t built by clinicians at all.

If you have patients asking about contingency access and you don’t feel confident prescribing in this space yourself, you can refer them to us at Jase.com. Going forward, we’ll be sharing how we make these clinical decisions, the criteria we use, the frameworks we’re building, and where we’re still figuring things out, so providers have something concrete to point to and more confidence in what to do when a patient asks.

Public knowledge gets better when clinicians chart the grey area in public instead of letting the internet do it. Real resources for providers, real guidance for patients, less grey area going forward. That’s what we’re here to help build.

The Bottom Line

Patients are already making decisions about contingency antibiotics. They are doing it with or without us. The only real question is whether those decisions get made with a real prescriber attached and a US pharmacy on the other end, or alone in a search bar at 11pm.

Public health framing has historically started at “don’t.” Patients have been hearing “don’t” without an alternative long enough that the grey market filled the silence. Clinicians shouldn’t have to choose between giving a defensible “no” and watching their patient land somewhere worse.

Sources

1. 21 U.S.C. § 353(b), Federal Food, Drug, and Cosmetic Act, Section 503(b) — Prescription drug requirements for federally regulated drugs.
2. U.S. Food and Drug Administration, BeSafeRx: Your Source for Online Pharmacy Information. FDA consumer protection program for identifying licensed online pharmacies.